首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   82330篇
  免费   6252篇
  国内免费   172篇
耳鼻咽喉   1086篇
儿科学   2376篇
妇产科学   1935篇
基础医学   13742篇
口腔科学   1957篇
临床医学   7627篇
内科学   16429篇
皮肤病学   1233篇
神经病学   7731篇
特种医学   3362篇
外国民族医学   46篇
外科学   10339篇
综合类   603篇
一般理论   89篇
预防医学   7115篇
眼科学   1512篇
药学   5892篇
中国医学   172篇
肿瘤学   5508篇
  2022年   445篇
  2021年   1399篇
  2020年   899篇
  2019年   1255篇
  2018年   1563篇
  2017年   1137篇
  2016年   1310篇
  2015年   1570篇
  2014年   1968篇
  2013年   3127篇
  2012年   4230篇
  2011年   4354篇
  2010年   2821篇
  2009年   2493篇
  2008年   3848篇
  2007年   4045篇
  2006年   3970篇
  2005年   3802篇
  2004年   3683篇
  2003年   3444篇
  2002年   3360篇
  2001年   2739篇
  2000年   2791篇
  1999年   2514篇
  1998年   1119篇
  1997年   933篇
  1996年   844篇
  1995年   839篇
  1994年   717篇
  1993年   759篇
  1992年   1779篇
  1991年   1690篇
  1990年   1632篇
  1989年   1617篇
  1988年   1349篇
  1987年   1320篇
  1986年   1232篇
  1985年   1160篇
  1984年   825篇
  1983年   755篇
  1982年   520篇
  1981年   506篇
  1980年   422篇
  1979年   694篇
  1978年   418篇
  1977年   398篇
  1975年   414篇
  1974年   470篇
  1973年   383篇
  1972年   380篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
4.
5.
6.
7.
8.
9.

Background

Early dumping is a poorly defined and incompletely understood complication after Roux-en-Y gastric (RYGB).

Objective

We performed a mixed-meal tolerance test in patients after RYGB to address the prevalence of early dumping and to gain further insight into its pathophysiology.

Setting

The study was conducted in a regional hospital in the northern part of the Netherlands.

Methods

From a random sample of patients who underwent primary RYGB between 2008 and 2011, 46 patients completed the mixed-meal tolerance test. The dumping severity score for early dumping was assessed every 30 minutes. A sum score at 30 or 60 minutes of ≥5 and an incremental score of ≥3 points were defined as indicating a high suspicion of early dumping. Blood samples were collected at baseline, every 10 minutes during the first half hour, and at 60 minutes after the start.

Results

The prevalence of a high suspicion of early dumping was 26%. No differences were seen for absolute hematocrit value, inactive glucagon-like peptide-1, and vasoactive intestinal peptide between patients with or without early dumping. Patients at high suspicion of early dumping had higher levels of active glucagon-like peptide-1 and peptide YY.

Conclusion

The prevalence of complaints at high suspicion of early dumping in a random population of patients after RYGB is 26% in response to a mixed-meal tolerance test. Postprandial increases in both glucagon-like peptide-1 and peptide YY are associated with symptoms of early dumping, suggesting gut L-cell overactivity in this syndrome.  相似文献   
10.
Clinical Oral Investigations - The aim of this study was the analysis of WNT10A variants in seven families of probands with various forms of tooth agenesis and self-reported family history of...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号